NYSE · CIK 0000920148
LH LABCORP HOLDINGS INC.
Insider trading from SEC Form 4. Last filing Mar 31, 2025. Close $312.15 on Oct 9, 2026, +28% from the 52-week low and -8% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
12
with a Form 4 at this company
Price and insider trades, last year
Signals
Open-market buys and sells at LABCORP HOLDINGS INC., scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 26Weak | sell | ANDERSON KERRII B director | $128k | 500 | -4% | +21% from low · -1% from high | |
| 8Weak | sell10b5-1 | ANDERSON KERRII B director | $235k | 1,000 | -7% | +11% from low · -4% from high | |
| 50Moderate | sell 4 | EISENBERG GLENN A Executive Vice President | $2.8M | 11,711 | -27% | - | |
| 48Moderate | sell 4 | Gilliland Dwight Gary director | $241k | 1,000 | -11% | - | |
| 48Moderate | sell 5 | Summy Amy B. EVP, Chief Marketing Officer | $877k | 3,672 | -46% | - | |
| 53Moderate | sell 5 | van der Vaart Sandra D EVP, Chief Legal Officer | $239k | 1,000 | -27% | - | |
| 45Moderate | sell 310b5-1 | Schechter Adam H President & CEO | $1.5M | 6,189 | -7% | - | |
| 8Weak | sell10b5-1 | ANDERSON KERRII B director | $230k | 1,000 | -7% | - |
Congressional trades
20 trades in LH disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| April McClain Delaney House · D-MD | Sale | LH Labcorp Holdings Inc. Common Stock | $100k to $250k | Aug 25, 2026 | 15 days after the trade |
| April McClain Delaney House · D-MD | Partial sale | LH Labcorp Holdings Inc. Common Stock | $1,001 to $15k | Aug 7, 2026 | 33 days after the trade |
| April McClain Delaney House · D-MD | Partial sale | LH Labcorp Holdings Inc. Common Stock | $1,001 to $15k | Aug 6, 2026 | 34 days after the trade |
| April McClain Delaney House · D-MD | Partial sale | LH Labcorp Holdings Inc. Common Stock | $1,001 to $15k | Aug 5, 2026 | 35 days after the trade |
| Alan Armstrong Senate · R-OK | Purchase | LH Labcorp Holdings Inc. Common Stock | $1,001 to $15k | Mar 27, 2026 | 116 days after the trade |
| April McClain Delaney House · D-MD | Purchase | LH Labcorp Holdings Inc. Common Stock | $1,001 to $15k | Feb 11, 2026 | 27 days after the trade |
| April McClain Delaney House · D-MD | Purchase | LH Labcorp Holdings Inc. Common Stock | $1,001 to $15k | Feb 4, 2026 | 34 days after the trade |
| April McClain Delaney House · D-MD | Purchase | LH Labcorp Holdings Inc. Common Stock | $1,001 to $15k | Jan 28, 2026 | 5 days after the trade |
| April McClain Delaney House · D-MD | Purchase | LH Labcorp Holdings Inc. Common Stock | $1,001 to $15k | Nov 17, 2025 | 21 days after the trade |
| April McClain Delaney House · D-MD | Purchase | LH Labcorp Holdings Inc. Common Stock | $1,001 to $15k | Oct 29, 2025 | 6 days after the trade |
| April McClain Delaney House · D-MD | Purchase | LH Labcorp Holdings Inc. Common Stock | $1,001 to $15k | Oct 31, 2025 | 4 days after the trade |
| Robert P. Bresnahan, Jr. House · R-PA | Purchase | LH Labcorp Holdings Inc. Common Stock | $1,001 to $15k | May 15, 2025 | 16 days after the trade |
| Robert P. Bresnahan, Jr. House · R-PA | Sale | LH Labcorp Holdings Inc. Common Stock | $1,001 to $15k | Apr 8, 2025 | 30 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Partial sale | LH Labcorp Holdings Inc. Common Stock | $1,001 to $15k | Mar 31, 2025 | 7 days after the trade |
| Robert P. Bresnahan, Jr. House · R-PA | Purchase | LH Labcorp Holdings Inc. Common Stock | $1,001 to $15k | Feb 25, 2025 | 30 days after the trade |
| April McClain Delaney House · D-MD | Purchase | LH Labcorp Holdings Inc. Common Stock | $1,001 to $15k | Feb 8, 2025 | 40 days after the trade |
| April McClain Delaney House · D-MD | Purchase | LH Labcorp Holdings Inc. Common Stock | $1,001 to $15k | Feb 17, 2025 | 31 days after the trade |
| April McClain Delaney House · D-MD | Purchase | LH Labcorp Holdings Inc. Common Stock | $1,001 to $15k | Feb 27, 2025 | 21 days after the trade |
| April McClain Delaney House · D-MD | Purchase | LH Labcorp Holdings Inc. Common Stock | $1,001 to $15k | Feb 28, 2025 | 20 days after the trade |
| April McClain Delaney House · D-MD | Purchase | LH Labcorp Holdings Inc. Common Stock | $1,001 to $15k | Feb 5, 2025 | 43 days after the trade |
Transactions
The last 62 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 27, 2025 | BERBERIAN LANCE EVP, Special Advisor, Strategy | AGrant or award Common Stock | +3,325 | $0.00 | $0 | 20,005 | Mar 31, 2025 |
| Mar 27, 2025 | Caveney Brian J EVP, Pres of ED, CMO & CSO | AGrant or award Common Stock | +4,840 | $0.00 | $0 | 34,176 | Mar 31, 2025 |
| Mar 27, 2025 | BERBERIAN LANCE EVP, Special Advisor, Strategy | FTax withholding Common Stock | -1,353 | $231.67 | $313k | 18,652 | Mar 31, 2025 |
| Mar 27, 2025 | Caveney Brian J EVP, Pres of ED, CMO & CSO | FTax withholding Common Stock | -2,109 | $231.67 | $489k | 32,067 | Mar 31, 2025 |
| Mar 5, 2025 | ANDERSON KERRII B director | SOpen-market sale Common Stock | -500 | $255.63 | $128k | 13,166 | Mar 7, 2025 |
| Feb 11, 2025 | ANDERSON KERRII B director | AGrant or award Restricted Stock Unitderivative | +897 | $0.00 | $0 | 897 | Feb 13, 2025 |
| Feb 11, 2025 | BERBERIAN LANCE EVP, Special Advisor, Strategy | MOption exercise Common Stock | +323 | - | - | 16,766 | Feb 13, 2025 |
| Feb 11, 2025 | Davis Jeffrey A. director | AGrant or award Restricted Stock Unitderivative | +897 | $0.00 | $0 | 897 | Feb 13, 2025 |
| Feb 11, 2025 | Bailey Megan D. EVP, Pres, Central Labs & Intl | AGrant or award Non-qualified Stock Optionsderivative | +3,700 | $0.00 | $0 | 3,700 | Feb 13, 2025 |
| Feb 11, 2025 | Caveney Brian J EVP, Pres of ED, CMO & CSO | MOption exercise Common Stock | +473 | - | - | 29,472 | Feb 13, 2025 |
| Feb 11, 2025 | Caveney Brian J EVP, Pres of ED, CMO & CSO | FTax withholding Common Stock | -136 | $245.14 | $33k | 29,336 | Feb 13, 2025 |
| Feb 11, 2025 | Bailey Megan D. EVP, Pres, Central Labs & Intl | AGrant or award Restricted Stock Unitderivative | +1,210 | $0.00 | $0 | 7,256 | Feb 13, 2025 |
| Feb 11, 2025 | BERBERIAN LANCE EVP, Special Advisor, Strategy | FTax withholding Common Stock | -86 | $245.14 | $21k | 16,680 | Feb 13, 2025 |
| Feb 11, 2025 | BERBERIAN LANCE EVP, Special Advisor, Strategy | MOption exercise Restricted Stock Unitderivative | -323 | $0.00 | $0 | 1,067 | Feb 13, 2025 |
| Feb 11, 2025 | Caveney Brian J EVP, Pres of ED, CMO & CSO | AGrant or award Non-qualified Stock Optionsderivative | +6,700 | $0.00 | $0 | 6,700 | Feb 13, 2025 |
| Feb 11, 2025 | Caveney Brian J EVP, Pres of ED, CMO & CSO | AGrant or award Restricted Stock Unitderivative | +2,220 | $0.00 | $0 | 4,661 | Feb 13, 2025 |
| Feb 11, 2025 | Caveney Brian J EVP, Pres of ED, CMO & CSO | MOption exercise Restricted Stock Unitderivative | -473 | $0.00 | $0 | 4,188 | Feb 13, 2025 |
| Feb 6, 2025 | Caveney Brian J EVP, Pres of ED, CMO & CSO | MOption exercise Common Stock | +670 | - | - | 28,764 | Feb 10, 2025 |
| Feb 6, 2025 | Bailey Megan D. EVP, Pres, Central Labs & Intl | MOption exercise Common Stock | +180 | - | - | 616 | Feb 10, 2025 |
| Feb 6, 2025 | BERBERIAN LANCE EVP, Special Advisor, Strategy | MOption exercise Common Stock | +356 | - | - | 16,277 | Feb 10, 2025 |
| Feb 6, 2025 | ANDERSON KERRII B director | MOption exercise Common Stock | +944 | - | - | 13,666 | Feb 10, 2025 |
| Feb 6, 2025 | Davis Jeffrey A. director | MOption exercise Common Stock | +944 | - | - | 4,563 | Feb 10, 2025 |
| Feb 6, 2025 | Caveney Brian J EVP, Pres of ED, CMO & CSO | FTax withholding Common Stock | -212 | $247.74 | $53k | 28,552 | Feb 10, 2025 |
| Feb 6, 2025 | Davis Jeffrey A. director | MOption exercise Restricted Stock Unitderivative | -944 | $0.00 | $0 | 0 | Feb 10, 2025 |
| Feb 6, 2025 | Bailey Megan D. EVP, Pres, Central Labs & Intl | FTax withholding Common Stock | -70 | $247.74 | $17k | 546 | Feb 10, 2025 |
| Feb 6, 2025 | BERBERIAN LANCE EVP, Special Advisor, Strategy | FTax withholding Common Stock | -94 | $247.74 | $23k | 16,183 | Feb 10, 2025 |
| Feb 7, 2025 | Caveney Brian J EVP, Pres of ED, CMO & CSO | MOption exercise Common Stock | +517 | - | - | 29,069 | Feb 10, 2025 |
| Feb 7, 2025 | BERBERIAN LANCE EVP, Special Advisor, Strategy | MOption exercise Common Stock | +354 | - | - | 16,537 | Feb 10, 2025 |
| Feb 7, 2025 | Bailey Megan D. EVP, Pres, Central Labs & Intl | MOption exercise Common Stock | +224 | - | - | 770 | Feb 10, 2025 |
| Feb 7, 2025 | Caveney Brian J EVP, Pres of ED, CMO & CSO | FTax withholding Common Stock | -149 | $246.27 | $37k | 28,920 | Feb 10, 2025 |
| Feb 7, 2025 | Bailey Megan D. EVP, Pres, Central Labs & Intl | FTax withholding Common Stock | -85 | $246.27 | $21k | 685 | Feb 10, 2025 |
| Feb 6, 2025 | ANDERSON KERRII B director | MOption exercise Restricted Stock Unitderivative | -944 | $0.00 | $0 | 0 | Feb 10, 2025 |
| Feb 7, 2025 | BERBERIAN LANCE EVP, Special Advisor, Strategy | FTax withholding Common Stock | -94 | $246.27 | $23k | 16,443 | Feb 10, 2025 |
| Feb 7, 2025 | Bailey Megan D. EVP, Pres, Central Labs & Intl | MOption exercise Common Stock | +67 | - | - | 752 | Feb 10, 2025 |
| Feb 7, 2025 | Caveney Brian J EVP, Pres of ED, CMO & CSO | MOption exercise Common Stock | +112 | - | - | 29,032 | Feb 10, 2025 |
| Feb 6, 2025 | BERBERIAN LANCE EVP, Special Advisor, Strategy | MOption exercise Restricted Stock Unitderivative | -356 | $0.00 | $0 | 1,744 | Feb 10, 2025 |
| Feb 7, 2025 | Bailey Megan D. EVP, Pres, Central Labs & Intl | FTax withholding Common Stock | -22 | $246.27 | $5,418 | 730 | Feb 10, 2025 |
| Feb 7, 2025 | BERBERIAN LANCE EVP, Special Advisor, Strategy | MOption exercise Restricted Stock Unitderivative | -354 | $0.00 | $0 | 1,390 | Feb 10, 2025 |
| Feb 7, 2025 | Caveney Brian J EVP, Pres of ED, CMO & CSO | FTax withholding Common Stock | -33 | $246.27 | $8,127 | 28,999 | Feb 10, 2025 |
| Feb 6, 2025 | Bailey Megan D. EVP, Pres, Central Labs & Intl | MOption exercise Restricted Stock Unitderivative | -180 | $0.00 | $0 | 6,337 | Feb 10, 2025 |
| Feb 6, 2025 | Caveney Brian J EVP, Pres of ED, CMO & CSO | MOption exercise Restricted Stock Unitderivative | -670 | $0.00 | $0 | 3,070 | Feb 10, 2025 |
| Feb 7, 2025 | Caveney Brian J EVP, Pres of ED, CMO & CSO | MOption exercise Restricted Stock Unitderivative | -517 | $0.00 | $0 | 2,553 | Feb 10, 2025 |
| Feb 7, 2025 | Bailey Megan D. EVP, Pres, Central Labs & Intl | MOption exercise Restricted Stock Unitderivative | -224 | $0.00 | $0 | 6,113 | Feb 10, 2025 |
| Feb 7, 2025 | Caveney Brian J EVP, Pres of ED, CMO & CSO | MOption exercise Restricted Stock Unitderivative | -112 | $0.00 | $0 | 2,441 | Feb 10, 2025 |
| Feb 7, 2025 | Bailey Megan D. EVP, Pres, Central Labs & Intl | MOption exercise Restricted Stock Unitderivative | -67 | $0.00 | $0 | 6,046 | Feb 10, 2025 |
| Jan 7, 2025 | ANDERSON KERRII B director | SOpen-market sale Common Stock10b5-1 | -1,000 | $235.00 | $235k | 12,722 | Jan 8, 2025 |
| Dec 2, 2024 | EISENBERG GLENN A Executive Vice President | MOption exercise Common Stock | +8,923 | $209.25 | $1.9M | 40,212 | Dec 4, 2024 |
| Dec 2, 2024 | Wang Julia Aijun Chief Financial Officer, EVP | AGrant or award Non-qualified Stock Optionsderivative | +8,100 | $0.00 | $0 | 8,100 | Dec 4, 2024 |
| Dec 2, 2024 | Gilliland Dwight Gary director | SOpen-market sale Common Stock | -1,000 | $241.00 | $241k | 7,712 | Dec 4, 2024 |
| Dec 2, 2024 | Wang Julia Aijun Chief Financial Officer, EVP | AGrant or award Restricted Stock Unitderivative | +2,680 | $0.00 | $0 | 2,680 | Dec 4, 2024 |
| Dec 2, 2024 | EISENBERG GLENN A Executive Vice President | MOption exercise Common Stock | +2,788 | $221.67 | $618k | 43,000 | Dec 4, 2024 |
| Dec 2, 2024 | EISENBERG GLENN A Executive Vice President | SOpen-market sale Common Stock | -11,711 | $240.43 | $2.8M | 31,289 | Dec 4, 2024 |
| Dec 2, 2024 | EISENBERG GLENN A Executive Vice President | MOption exercise Non-qualified Stock Optionsderivative | -8,923 | $0.00 | $0 | 0 | Dec 4, 2024 |
| Dec 2, 2024 | EISENBERG GLENN A Executive Vice President | MOption exercise Non-qualified Stock Optionsderivative | -2,788 | $0.00 | $0 | 5,577 | Dec 4, 2024 |
| Nov 22, 2024 | Summy Amy B. EVP, Chief Marketing Officer | MOption exercise Common Stock | +4,015 | $168.52 | $677k | 7,990 | Nov 26, 2024 |
| Nov 22, 2024 | Summy Amy B. EVP, Chief Marketing Officer | SOpen-market sale Common Stock | -3,672 | $238.91 | $877k | 4,319 | Nov 26, 2024 |
| Nov 22, 2024 | Summy Amy B. EVP, Chief Marketing Officer | MOption exercise Non-qualified Stock Optionsderivative | -4,015 | $0.00 | $0 | 0 | Nov 26, 2024 |
| Nov 21, 2024 | van der Vaart Sandra D EVP, Chief Legal Officer | SOpen-market sale Common Stock | -1,000 | $239.42 | $239k | 2,670 | Nov 25, 2024 |
| Nov 11, 2024 | Schechter Adam H President & CEO | SOpen-market sale Common Stock10b5-1 | -6,189 | $243.47 | $1.5M | 87,441 | Nov 13, 2024 |
| Nov 1, 2024 | Bailey Megan D. EVP, Pres, Central Labs & Intl | AGrant or award Restricted Stock Unitderivative | +1,110 | $0.00 | $0 | 6,517 | Nov 5, 2024 |
| Nov 1, 2024 | Oyegunwa Akinbolade EVP, CIO & CTO | AGrant or award Restricted Stock Unitderivative | +1,110 | $0.00 | $0 | 2,082 | Nov 5, 2024 |
| Oct 24, 2024 | ANDERSON KERRII B director | SOpen-market sale Common Stock10b5-1 | -1,000 | $230.00 | $230k | 13,722 | Oct 25, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- ANDERSON KERRII Bdirector
- BERBERIAN LANCEEVP, Special Advisor, Strategy
- Bailey Megan D.EVP, Pres, Central Labs & Intl
- Caveney Brian JEVP, Pres of ED, CMO & CSO
- Davis Jeffrey A.cfo, officer, director
- EISENBERG GLENN AExecutive Vice President
- Gilliland Dwight Garydirector
- Oyegunwa AkinboladeEVP, CIO & CTO
- Schechter Adam HPresident & CEO
- Summy Amy B.EVP, Chief Marketing Officer
- Wang Julia AijunChief Financial Officer, EVP
- van der Vaart Sandra DEVP, Chief Legal Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.